Characteristics and Outcomes of People With COPD Who Experience Exacerbations While on Inhaled Triple Therapy: Results of the SIRIUS I Cohort Study in the US (2015&ndash;2019)

Clementine Nordon,1 Donna Carstens,2 Malin Fagerås,3 Hana Müllerová,1 Phani S Veeranki,4 João André Alves,3 Hayley D Germack,2 Timothy L Barnes,4 Meredith C McCormack5 1Respiratory Evidence Strategy, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK; 2US Medical Evidence, Biopharmaceuticals, As...

Full description

Saved in:

Bibliographic Details
Main Authors:	Nordon C, Carstens D, Fagerås M, Müllerová H, Veeranki PS, Alves JA, Germack HD, Barnes TL, McCormack MC
Format:	Article
Language:	English
Published:	Dove Medical Press 2025-06-01
Series:	International Journal of COPD
Subjects:	COPD burden of illness exacerbation inhaled triple therapy mortality healthcare resource utilization
Online Access:	https://www.dovepress.com/characteristics-and-outcomes-of-people-with-copd-who-experience-exacer-peer-reviewed-fulltext-article-COPD
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Characteristics and Outcomes of People With COPD Who Experience Exacerbations While on Inhaled Triple Therapy: Results of the SIRIUS I Cohort Study in the US (2015&amp;ndash;2019)

Similar Items

Characteristics and Outcomes of People With COPD Who Experience Exacerbations While on Inhaled Triple Therapy: Results of the SIRIUS I Cohort Study in the US (2015–2019)